# Schooner Capital

Investor in Boston, Massachusetts

## About Schooner Capital

Schooner Capital invests in private companies from a permanent capital base. We look across sectors, stage, and geography, with a premium on independent judgment and contrarian thinking.

Patience has been fundamental to our approach for 55 years. We often invest multiple times in our holdings and favor deep partnership with exceptional teams. Our evergreen structure and entrepreneurial roots allow us to respond to opportunities without mandate constraints or fundraising concerns.

Our profits support The Schooner Foundation, which is involved in human rights causes around the world.

Private Investments Our private investment efforts focus primarily on technology, healthcare, and services companies, at all stages. We work closely with our CEOs and leadership teams to build great businesses.

Public Equities Our public investment efforts are global in scope and highly concentrated in nature, comprised of leading companies with exceptional teams and returns on invested capital.

## People

- **Peter Binas**, Chief Investment Officer

## Key Facts

- **Location:** Boston, Massachusetts
- **Investor Type:** Private Equity
- **Founded:** 1971

## Investment Industries

- Biotech
- E-Commerce
- Entertainment
- Health and Wellness
- Medical/Healthcare
- Technology/Web/App
- Other

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/schooner-capital
- More investors: [Biotech Investors in Massachusetts](https://askforfunding.com/site/angel-investors/massachusetts/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.